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Study Objectives: To test whether the sleep-wake cycle disruption in patients hospitalized with 
traumatic brain injury (TBI) 1) is also found in patients with traumatic injuries other than TBI (non-
TBI); and 2) is associated to a weaker or abnormal circadian clock signal.  
Methods: Forty-two non-mechanically ventilated and non-sedated patients hospitalized for moderate to 
severe TBI were compared to 34 non-TBI patients. They wore wrist actigraphs for 9.4±4.2 days, 
starting 19.3±12.6 days post-injury. Of these, 17 TBI and 14 non-TBI patients had their urine collected 
every hour for 25 h, starting 18.3±12.3 days post-injury. We calculated urinary 6-sulfatoxymelatonin 
concentration to obtain total 24 h excretion, excretion onset, offset, duration, amplitude and acrophase. 
Using Student’s t-tests, we compared groups on actigraphy (daytime activity ratio, nighttime total sleep 
time, and fragmentation index) and melatonin variables. We investigated associations between 
melatonin and actigraphy variables using Pearson’s correlations.  
Results: TBI patients had poorer daytime activity ratio (TBI: 77.5±9.4%; non-TBI: 84.6±6.9%), shorter 
nighttime total sleep time (TBI: 353.5±96.6 min; non-TBI: 421.2±72.2 min), and higher fragmentation 
index (TBI: 72.2±30.0; non-TBI: 53.5±23.6) (all p-values<0.01). A melatonin rhythm was present in 
both groups, and no group differences were found on melatonin variables. No associations were found 
between melatonin and actigraphy variables in TBI patients.  
Conclusion: Moderate to severe TBI patients have more serious sleep-wake disturbances than non-TBI 
patients hospitalized in the same environment, suggesting that the brain injury itself alters the sleep-
wake cycle. Despite their deregulated 24 h sleep-wake cycle, TBI patients have a normal circadian 
clock signal. 
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Statement of Significance 
This is the first study to assess melatonin rhythm in hospitalized patients with a traumatic brain 
injury but who are not mechanically ventilated or continuously sedated, and to use hospitalized trauma 
patients without TBI to compare sleep-wake and melatonin data, thus controlling for important medical 
and environmental confounds. Actigraphic results showed more severe sleep-wake disturbances in TBI 
compared to non-TBI patients, supporting a role of the brain injury itself in the sleep-wake disturbances 
observed during the hospital stay. However, sleep-wake disturbances do not appear to result from a 
trauma to the central circadian clock since the 24-h melatonin rhythm of TBI patients was normal. As a 






A majority of patients with moderate to severe traumatic brain injury (TBI) suffer from 
persistent sleep-wake disturbances.1 Patients complain of fragmented sleep at night and of difficulties 
staying awake during the day. These sleep-wake disturbances seriously limit their functional recovery. 
We previously reported that sleep-wake disturbances, with severe fragmentation of sleep and wake 
episodes, were already present during the hospital stay, after continuous sedation was discontinued and 
patients had reached medical stability.2-4 We also observed that only 50% of these patients regain their 
ability to maintain continuous periods of daytime wakefulness and nighttime sleep during their hospital 
stay.2 Notably, those who returned to a consolidated sleep-wake cycle were also those who showed 
better recovery from posttraumatic amnesia and lower disability at hospital discharge.2 A better 
understanding of the causes underlying sleep-wake disturbances in TBI patients during their hospital 
stay, including the specific contribution of the brain injury itself, may help develop appropriate 
interventions to restore sleep-wake consolidation and, potentially, accelerate functional recovery of 
TBI patients.  
 Among the possible causes of sleep-wake disturbances observed in hospitalized TBI patients, 
the most obvious suspects are environmental factors and those associated with pain, medication and 
frequent nursing care interventions.5 As these factors are common to all hospitalized patients with 
severe trauma, comparing TBI patients to patients with severe traumatic injuries but no TBI (non-TBI 
patients, e.g. orthopedic and spinal cord injuries) may help to identify the specific contribution of brain 
injury to sleep-wake disturbances. 
Another possible cause of sleep-wake disturbances in TBI patients is damage to the complex 
neural pathways involved in the circadian control of sleep-wake regulation. The main circadian clock, 
located in the suprachiasmatic nuclei of the hypothalamus, generates rhythms of about 24 h for all 
physiological and behavioral functions, including sleep timing. A robust circadian signal is essential to 
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a well-consolidated sleep-wake cycle, with a main sleep episode at night and a long, sustained period of 
alert wakefulness during the day.6 Conversely, a weak or disrupted circadian signal results in 
perturbations similar to those documented in hospitalized TBI patients, including fragmented nighttime 
sleep and excessive sleepiness and naps during the daytime.2-4 
A recognized marker of circadian output is pineal melatonin production, whose timing is tightly 
controlled by the main circadian clock.7 When the circadian clock is correctly synchronized to the 
external day-night cycle, melatonin production shows elevated levels by night and is almost 
undetectable by day. The few studies that have investigated the melatonin rhythms of TBI patients 
hospitalized in the ICU reported decreased melatonin production and a disturbed melatonin rhythm.8-10 
However, all of these studies were conducted among mechanically ventilated patients who were under 
continuous sedation, which not only prevents the observation a natural sleep-wake cycle but could also 
directly alters circadian function and melatonin production.11 To date, no study has examined the 
melatonin rhythm concurrently with the sleep-wake cycle in non-sedated hospitalized TBI patients. 
In the present study, we first tested whether TBI patients in the acute phase post-injury, no 
longer mechanically ventilated or continuously sedated, have more severe sleep-wake cycle 
disturbances than non-TBI patients with severe traumatic injuries, hospitalized in the same 
environment. Secondly, we compared the melatonin rhythm of TBI patients to that of non-TBI patients 
and assessed whether an abnormal circadian rhythm of melatonin production was associated with the 






Forty-two moderate to severe TBI patients were recruited from Hôpital du Sacré-Coeur de 
Montréal, a level-1 trauma center affiliated to the Université de Montréal, between January 2010 and 
June 2016. TBI was defined as an alteration in brain function or other evidence of brain pathology 
caused by an external force,12 and TBI severity was assessed upon emergency department admission, 
prior to intubation, using the Glasgow Coma Scale (GCS).13 TBI patients were included if they were 
hospitalized in the ICU for their TBI.  
Thirty-four non-TBI patients having suffered severe traumatic injuries (i.e. orthopedic and/or 
spinal cord injuries) and requiring extensive medical care and medication were recruited for the control 
group. They were recruited from the same hospital between January 2012 and January 2016. Severe 
orthopedic injury was defined as a complex traumatic injury, such as multiple fractures with or without 
damage to peripheral nerves or to the vascular system, which necessitates intervention by a specialized 
multidisciplinary team. Although it is difficult to completely rule out mild TBI in patients with 
orthopedic and spinal cord injury, no patient from the non-TBI group had evidence of brain injury on 
the CT scan.  
Patients were excluded if they were younger than 16 or older than 65 years old; were 
quadriplegic; had a history of substance abuse, had a diagnosed psychiatric, neurological or sleep 
disorder prior to injury; suffered any damage to both eyes or the optic nerve (modifying light 
perception); or if they had a prior history of TBI. Written informed consent for participation was 
obtained from patients’ families, and the study was approved by the hospital ethics committee.  
Thirty patients of the TBI group were also included as participants in one, two or three previous 
publications aiming at answering different questions.2,4,14 
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Measures 
Clinical and demographic measures 
Age, sex, GCS score at admission, mechanism of injury, length of ICU stay and hospital length 
of stay where recorded in both groups. The Injury Severity Score, a scale that assesses severity of 
traumatic injuries based on work injury of six body systems	 (i.e. head/neck, face, chest, abdomen, 
extremity, external), was also calculated to represent overall injury severity.15 We also calculated the 
mean daily dose of sedatives and analgesics (lorazepam, midazolam, propofol, morphine, 
hydromorphones, and fentanyl) administered during actigraphy recording. 
Sleep-wake assessments 
 Sleep-wake cycle disturbances were assessed using actigraphy. Patients wore a wrist actigraph 
(Actiwatch-L or Actiwatch-Spectrum, Philips Healthcare, Andover, MA) on a non-paralyzed arm 
starting in the ICU, and continuing throughout hospitalization on regular neurological/orthopedic 
wards. To obtain a meaningful assessment of the sleep-wake cycle, actigraphy recordings began when 
continuous sedation and analgesia had ceased for at least 24 h, and once patients reached a score ≥3 on 
the Rancho Los Amigos scale,16 indicative of apparent physical reactivity to internal and external 
stimuli. At this stage, patients had reached medical stability, defined by the absence of mechanical 
ventilation, fever, active infections, hemodynamic instability, and elevated intracranial pressure. 
 Data from the actigraphs were uploaded into dedicated software (Actiware 5.0) and activity 
counts were derived per 1 min epoch. For all days of actigraphy recording, activity counts were 
summed for the daytime (7:00-21:59) and for nighttime (22:00-6:59). Daytime and nighttime were 
identified according to the light/dark schedule of the hospital. We measured consolidation of the 24 h 
sleep-wake cycle using the daytime activity ratio (DAR), as previously described.2,4 The DAR is the 
ratio of total 24 h activity occurring in the daytime (daytime activity/24 h activity). Therefore, a higher 
DAR represents a better consolidation of activity in the daytime and of rest in the nighttime.  
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 In addition to sleep-wake cycle assessments, the Actiware scoring program was applied to 
nighttime actigraphic data (22:00-6:59) to calculate two parameters estimating nighttime sleep, using 
an automatic wake detection threshold of 40 activity counts per minute: 1) total sleep time, which is the 
number of minutes scored as sleep during the nighttime period, and 2) nighttime fragmentation index, 
which is an index of restlessness that quantifies the frequency of switches between immobility and 
mobility as an estimate of the frequency of sleep interruptions. 
Assessment of melatonin rhythm	
 Melatonin production was estimated using the urinary excretion of 6-sulphatoxymelatonin 
(aMT6s), melatonin’s main metabolite.7,17 Characteristics of the 24-h melatonin rhythm were evaluated 
in a subset of 17 TBI and 14 non-TBI patients, before or during their actigraphic assessment. These 
patients were wearing a urinary catheter, which allowed for hourly urine collection without perturbing 
the patient’s sleep. This approach also had the advantage of not requiring the collaboration of patients 
who were still agitated or confused. Collection of all urine also provided the opportunity to estimate 
total 24-h melatonin production in addition to hourly concentration of aMT6s.18  
 During the 24-h period of urine collection, the entire contents of the urine drainage bag was 
collected every hour. After measuring total volume, urine was frozen at -20°C in two 5-mL aliquots. 
Hourly concentration of aMT6s (in ng/mL) was assessed in duplicate using Bühlmann ELISA kits 
(ALPCO Diagnostics, Windham, NH, USA). The kit used had a minimum detection limit of 1.5 ng/ml, 
an intra-assay variation of 7.1% and an inter-assay variation of 11.9%. To obtain total 24-h excretion 
(ng), the concentration of aMT6s in each sample was multiplied by the volume and results from all 24 
samples were added. The onset and offset of melatonin secretion were estimated by the hour of 
sampling at which aMT6s concentration exceeded the average of the three preceding (onset) or 
following (offset) samples by 100%.19,20 Duration of melatonin secretion was defined as the interval 
between estimated onset and offset. A cosinor analysis21 was also carried out to quantify amplitude 
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(difference between estimated peak value and estimated mean value, in ng/mL) and acrophase (clock 
time of the estimated peak value, in h) of the rhythm.  
Statistical Analyses 
Using Student’s t-tests, TBI and non-TBI groups were compared on variables assessed with 
actigraphy and aMT6s excretion. Chi-square statistics were used to compare nominal data. Bivariate 
correlation analyses were carried out using Pearson’s correlation coefficient to assess associations 
between actigraphy and aMT6s variables in TBI patients. Statistical significance was set at p < 0.05. 
Results 
Patient characteristics 
 Both patient groups were comparable for age and sex (Table 1), and in both groups, the main 
mechanism of injury was a motor vehicle accident. The TBI group had a longer length of ICU stay and 
hospital length of stay. Mean daily dose of analgesics during actigraphy recording was higher in the 
non-TBI group than in the TBI group. 
Sleep-wake cycle and nighttime sleep quality assessed with actigraphy 
On average, patients wore the actigraph for 9.5 ± 4.2 days with no significant difference 
between groups (Table 1). Actigraphic recordings started 16.7 ± 11.8 days post-injury; this delay was 
shorter for the non-TBI than the TBI group (Table 1).  
 Patients in the TBI group had a lower DAR than those in the non-TBI group (Table 2), 
reflecting that their sleep and wake periods were more randomly dispersed throughout the day and 
night. As in previous studies,2-4 we used a threshold ratio of 0.80 to define a consolidated sleep-wake 
cycle. Over the duration of the actigraphic recording, TBI patients had a higher percentage of days with 
a DAR < 0.80 than non-TBI patients (Table 2). 
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 Regarding estimated nighttime (22:00 – 6:59) total sleep time, patients in the TBI group slept 
on average 68 minutes less than non-TBI patients (Table 2). Sleep of TBI patients also showed a higher 
fragmentation index than non-TBI patients (Table 2), suggesting a more restless sleep. 
Melatonin rhythm estimated with urinary aMT6s excretion 
Urine collection took place 18.3 ± 12.3 days post-injury (TBI: 23.3 ± 14.1 days post-injury; 
non-TBI: 12.5 ± 6.4 days post-injury). In 11 TBI and 5 non-TBI patients, actigraphy recording could 
not be conducted at the same time as urine collection but had to be postponed until their Rancho Los 
Amigos scale of cognitive functioning score (i.e. level of movement and physical reactivity to internal 
and external stimuli) reached ≥3 to provide valid recordings of their sleep-wake cycle. 16 On average, 
melatonin assessment occurred 1.6 ± 6.7 days before the start of actigraphy recording in TBI patients, 
and 1.4 ± 6.7 days after the start of actigraphic recording in non-TBI patients. In all patients, the 
melatonin rhythm was always assessed either before or during actigraphic recording. 
Hourly concentration of aMT6s excretion indicated the presence of a significant 24-h rhythm of 
melatonin production that was very similar in the two groups (Figure 1). As shown in Table 3, there 
was no significant difference on any descriptive variables, including timing of secretion (onset, offset 
and acrophase), total excretion and estimated amplitude. Although actigraphic variables were 
significantly different between the two sub-groups (Table 3), TBI patients had a circadian melatonin 
rhythm comparable to that of non-TBI patients (see Figure 2 for representative patients). Moreover, 
there was no significant correlation between actigraphic and melatonin variables, either for the entire 
group of patients (p-values > 0.09) or for the sub-group of TBI patients (p-values > 0.05).  These 
associations were still non-significant when correlations were restricted to the first 72 h following urine 
collection (this analysis was possible in 23 patients: 10 TBI and 13 non-TBI).  
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Discussion 
 We found more sleep-wake cycle disruptions in TBI patients than in non-TBI patients 
hospitalized in a similar environment, as shown by weaker sleep-wake cycle consolidation, as well as 
decreased sleep time and more restless sleep during the night. Despite having a more disturbed sleep-
wake cycle, TBI patients had a circadian melatonin rhythm comparable to that of non-TBI patients, in 
both timing and amplitude. Total melatonin production estimated with 24-h aMT6s excretion was also 
similar in the two groups. Moreover, characteristics of the melatonin circadian rhythm were not 
associated with the sleep-wake disturbances observed in TBI patients during their hospital stay. Our 
results bring new elements that support a role of the brain injury itself in the sleep-wake cycle 
disturbances observed in TBI patients during the hospital stay, and suggest that these disturbances are 
not caused by an alteration in the circadian output signal.  
 Our study is the first to use a hospitalized trauma population of non-TBI patients as a control 
group to compare sleep-wake and melatonin data, thus partially controlling for environmental and 
medical factors influencing sleep and circadian rhythms. Additionally, both patient groups were 
bedridden at the time of the study, which made actigraphic data comparable between the two groups. 
Results from non-TBI patients clearly show that it is possible to attain consolidated sleep-wake cycle 
during the hospital stay, in spite of pain, medication and frequent nursing care, and after a severe 
traumatic injury.  It is therefore unlikely that the severe sleep-wake disturbances observed in TBI 
patients result essentially from the hospital environment and conditions of nursing care, but rather point 
to the brain injury itself as the main source of these disturbances. 
Contrary to our results, previous studies systematically found a disruption in melatonin 
secretion in acute TBI.8-10 This discrepancy between our results and previous studies may be due to the 
fact that patients in previous studies were tested under continuous sedation and analgesia, and were 
mechanically ventilated. Continuous sedation and mechanical ventilation are major confounds in the 
	 12 
study of sleep and circadian rhythms.11,22 Our study is the first to measure the sleep-wake cycle and 
melatonin rhythm in the waking stage after TBI, being close to the injury itself and still in the acute 
phase, but enabling the assessment of a more naturally occurring sleep-wake cycle and melatonin 
rhythm than in previous studies. Moreover, quantifying urinary concentration of aMT6s on an hourly 
basis provided us with the ability to assess the phase of the melatonin rhythm, which previous acute 
studies were unable to do. Because our subgroup of patients were all wearing a urinary catheter, such 
frequent urine collection was possible without causing any sleep disruption, and collection of all urine 
allowed for the measurement of total 24-h melatonin production. 
Despite that nearly all TBI patients showed an absence of sleep-wake cycle consolidation in the 
first days of testing, the majority of them were within the normal range of 24 h aMT6s excretion for 
healthy adults,23 and the timing of melatonin production reflected a normal nocturnal rhythm, identical 
to the rhythm observed in non-TBI patients.24 As melatonin measures took place either slightly before 
or during actigraphy recording, they suggest that the circadian output signal was normal despite 
concomitant or subsequent sleep-wake cycle disturbances. Furthermore, the absence of correlation 
between actigraphy and melatonin variables shows that the circadian timing or amplitude was not 
related either to sleep-wake cycle consolidation or to estimated nighttime sleep quality. It is not 
possible to exclude the possibility that injury to the pathways linking the main circadian clock to brain 
areas involved in sleep-wake regulation contribute to sleep-wake disturbances, but our findings show 
that sleep-wake disturbances among non-sedated TBI patients are not caused by an impairment of the 
circadian signal itself. 
Our results contradict the hypotheses that the hospital environment and an altered circadian 
signal explain severe sleep-wake disturbances in TBI patients. However, even if transmission of the 
circadian signal is intact, it may be that the pathways responsible for subsequently maintaining sleep 
and wake are affected by the brain injury. The hypothalamus has a crucial role in sleep-wake 
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regulation, but it is also a vulnerable brain region in the context of a TBI.25 Disruption of hypothalamic 
function can result in deregulation of wake-promoting neurotransmitters, including orexin and 
histamine, two wake-promoting neurotransmitters. Another hypothesis suggests that a disconnection in 
the ascending reticular activating system (ARAS), a brain pathway that is key in regulating 
wakefulness, could also cause disruptions of wakefulness. As most ARAS regions, namely the pons, 
the hypothalamus and the thalamus, are vulnerable to TBI,25,26 disconnection in the ARAS could have a 
direct impact on TBI patients’ ability to remain awake for extensive periods of time, therefore leading 
to frequent short bouts of sleep.  
Dissociating the effects of injury, hospital environment and medication on sleep and circadian 
rhythms 
Dissociating the TBI from concomitant injuries, the hospital environment and the treatment 
intensity remains an important challenge in understanding the direct role of the brain injury in acute 
sleep-wake disturbances. Although our TBI and non-TBI groups were well matched in terms of age, 
sex, and absence of pre-existing neurological, psychiatric, or sleep disorders, the non-TBI group had 
lower Injury Severity Score, shorter ICU stay, and was hospitalized for a shorter period of time. These 
group differences were expected given the nature of the injuries of each patient group. It took a longer 
time for TBI patients than non-TBI patients to attain medical stability and a state when meaningful 
actigraphic assessments of the sleep-wake cycle could be performed. As a result, the interval between 
injury and data collection was longer in TBI than in non-TBI patients, yet TBI patients showed more 
severe sleep-wake disturbances. It is possible that the melatonin rhythm is altered in the first days after 
the TBI and then, returns to normal when medical stability is reached. However, since TBI patients are 
sedated in the first days post-injury, it is difficult to dissociate the effect of sedation from that of the 
brain injury itself.  
	 14 
Several studies indicate that key zeitgebers (e.g. light, feeding, pharmacological manipulations, 
social interactions) are profoundly disturbed in the hospital setting, particularly in the ICU.5,11,27,28 
These rhythm abnormalities can influence both the sleep-wake cycle and circadian function. Given that 
the TBI group had a significantly longer stay in the ICU than the non-TBI group, this may have 
contributed to their severely disturbed sleep-wake cycle. However, the fact that melatonin rhythm was 
normal despite sleep-wake cycle disturbances in the TBI group suggests that this disturbance was not 
of circadian origin, though it may have resulted in part from a prolonged exposure to the critical care 
environment. Unfortunately, it remains a challenge to dissociate the effect of the brain injury from that 
of a prolonged ICU stay. 
The non-TBI group also had a higher mean daily dose of analgesics during the actigraphy 
recording period, which may be due to the importance of their physical (non-brain) injuries. It may also 
be due to a greater ability to communicate pain than TBI patients. Proper relief from pain may be 
necessary to ensure sleep continuity in severely injured patients.27-30  
Limitations of the study 
 A limitation of the study was that the intensity and frequency of nursing care was not directly 
measured and could have fragmented sleep periods. Therefore, we cannot exclude that the higher 
fragmentation index observed in the TBI group compared to the non-TBI group could be due to 
frequent nurse or medical intervention.  
 Actigraphy has limitations to evaluate sleep quantity and quality. While high activity levels are 
expected to be incompatible with sleep, the correspondence between rest and sleep is more a matter of 
interpretation. Differences in estimates of sleep quantity and quality between TBI and non-TBI patients 
certainly reflect less restful sleep during nighttime in TBI patients, even if a precise evaluation of sleep 
quality and sleep architecture cannot be done. However, it is not possible to distinguish sleep from rest 
episodes when low levels of activity are recorded in bed-ridden patients. Because of this limitation, we 
have decided to not present total sleep time per 24 h in our two groups of patients. Despite these 
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limitations, actigraphy remains the method of choice to assess the sleep-wake cycle over many 
consecutive days. It is well tolerated in severely injured patients and proved to be a very useful and 
inexpensive tool to assess sleep-wake quality in hospitalized patients.  
 In 16 participants, it was not possible to record actigraphy and measure melatonin production at 
the same time. We were constrained to carry out urine collections when patients still had a urinary 
catheter, but at this point, many patients did not exhibit sufficient movements to render actigraphy 
recording possible or valid. Therefore, actigraphy had to be postponed for a few days in these patients. 
However, melatonin data was always collected either before or during actigraphy recording. Our 
conclusion is that a normal melatonin rhythm observed before or during actigraphic assessment 
excludes the possibility that sleep-wake disturbances were caused by an abnormal circadian output, as 
it is unlikely that a melatonin circadian rhythm disappears as the patient recovers.   
Conclusion 
 Using actigraphy, this study showed that non-mechanically ventilated and non-sedated patients 
hospitalized for a moderate to severe TBI have poorer sleep-wake cycle consolidation, shorter 
nighttime total sleep time and more sleep fragmentation than non-TBI patients hospitalized in the same 
environment. These results point to the role of the brain injury itself in altering sleep and wake 
regulation. Despite severe sleep-wake disturbances, TBI patients had a robust melatonin rhythm, and 
there was no association between characteristics of the melatonin rhythm and the observed sleep-wake 
disturbances during the hospital stay. Although many factors could influence the sleep-wake cycle of 
hospitalized TBI survivors, our study suggests that neural mechanisms other than the circadian clock 
may be responsible for post-TBI sleep-wake disturbances. Impacts of presenting such a poor sleep in 
the acute and post-acute stages of TBI on neuronal, cognitive and functional recovery are still 
emerging, but suggest that sleep disturbances and poorer brain recovery are associated.4 Since sleep is a 
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Table 1. Group characteristics (%; mean ± SD) of the patients with (TBI) or without (non-TBI) 






(n = 42) 
Non-TBI 
(n = 34) 
p-value 
Men / women (%) 69.0% 67.6% 0.90 
Age 31.1 ± 14.0 33.9 ± 15.2 0.41 
GCS at admission 7.8 ± 3.4 14.7 ± 1.2 <0.001 
Injury Severity Score 30.4 ± 10.6 19.8 ± 8.9 <0.001 
Length of ICU stay (days) 21.4 ± 13.7 4.9 ± 4.2 <0.001 
Hospital length of stay (days) 41.5 ± 24.8 25.1 ± 12.9 <0.001 
Start of actigraphy (days post-injury) 20.6 ± 13.0 11.8 ± 8.0 <0.001 
Length of actigraphy recording (days) 10.2 ± 4.6 8.5 ± 3.6 0.07 
Mean daily dose of sedatives 
administered during actigraphy (mg) 
0.3 ± 1.2  0.3 ±1.4 0.98 
Mean daily dose of analgesics 
administered during actigraphy (mg) 
4.9 ± 18.9 19.8 ± 18.0 <0.01 





Table 2. Sleep-wake cycle and nighttime sleep characteristics (mean ± SD) in patients with (TBI) 
or without (non-TBI) traumatic brain injury.  
 
Actigraphy variables TBI 
(n = 42) 
Non-TBI 
(n = 34) 
p-value 
Mean DAR (%) .78 ± 0.09 0.85 ± 0.07 <0.001 
Days with DAR<0.80 (% of recording) 48.8 ± 33.0 20.5 ± 28.3 <0.001 
Total sleep time*  (min) 353 ± 97 421 ± 73 0.002 
Mean fragmentation index* 72.2 ± 30.0 53.5 ± 23.6 0.006 
*nighttime; DAR: Daytime activity ratio; TBI: traumatic brain injury 
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Table 3. Characteristics (mean ± SD) of sleep-wake variables, 6-sulfatoxymelatonin (aMT6s) 
excretion and circadian estimates in the sub-groups of patients with (TBI) or without (non-TBI) 
traumatic brain injury. 
 
 TBI 
(n = 17) 
Non-TBI 
(n = 14) 
p-value 
Actigraphy Variables:    
Mean DAR 0.76 ± 0.09  0.86 ± 0.05 <0.001 
Days with DAR < 0.80 (% of 
recording) 
55.2 ± 28.9 20.4 ± 28.6 <0.01 
Total sleep time* (min) 346 ± 101 445 ± 54 <0.01 
Mean fragmentation index* 80.5 ± 34.0 54.7 ± 22.5 0.021 
aMT6s excretion:    
Total 24 h Excretion (ng) 14371 ± 9934 12845 ± 5652 0.62 
Onset (h:min) 23:25 ± 2:22 23:38 ± 1:54 0.77 
Offset (h:min) 08:07 ± 2:51 07:38 ± 1:44 0.59 
Duration of secretion (h) 8.7 ± 2.8 8.0 ± 2.08 0.44 
Circadian amplitude (ng/mL) 12.0 ± 7.5 8.1 ± 4.7 0.10 
Circadian acrophase (h:min) 05:08 ± 2:14 05:18 ± 1:35 0.81 






Figure 1.  Average 24 h melatonin profiles of the TBI and non-TBI groups 
Average 24 h profiles of urinary concentration of 6-sulphatoxymelatonin (aMT6s) for the TBI (solid 
line) and non-TBI (dashed line) groups. Data points represent the hourly concentrations of aMT6s 
(ng/ml), accumulated in the hour prior to the urine collection time reported on the x-axis. Error bars 





Figure 2.  Example of actograms and 24 h melatonin profiles of TBI and non-TBI patients 
Examples of typical actigraphic findings of a TBI (left) and a non-TBI patient (right), with 24 h profiles 
of urinary excretion of 6-sulphatoxymelatonin (aMT6s), corresponding to Day 2 of each actogram. For 
actograms (upper panels), total activity counts for each minute of recording are illustrated by vertical 
dark lines, on a scale of 0 to 1,000 activity counts. Daytime hours (07:00–22:00 hours) are shown in 
yellow and nighttime hours (22:00–07:00 hours) in blue. For 24 h profiles of aMT6s excretion (lower 
panels), data points represent hourly concentrations (ng/ml). 	
	
	
	
